PD

Philip Daffas

PainChek Ltd | Chief Executive Officer, Managing Director
Philip is global business leader and people manager with an international career spanning more than 25 years with blue-chip healthcare corporates and novel technology start-up companies. Philip has held senior global business leader positions in Europe, US and Australia. He has been in building businesses, growing market share and developing customer and industry relationships in each sector on a global basis. Philip's earlier experience was gained in Europe with market leaders such as IVAC infusion systems and Shiley cardiopulmonary products. He joined Boehringer Mannheim, initially in the UK managing their diagnostics business and subsequently was promoted to a Global Marketing role in the Diabetes Care business cased in Mannheim, Germany. In 1997 Philip joined Cochlear in the UK as the European Sales and Marketing Manager and subsequently was promoted in 2000 to the VP Global Marketing role based in Sydney, Australia Other roles in Australia have included General Manager with Roche Diagnostics, Managing Director at Bio-Rad Laboratories and CEO of Applied Physiology, an Australian software start-up company in the intensive care monitoring sector.

Company and Roles

Company
Title
Tenure
Since
PCK
PainChek Ltd
  • Chief Executive Officer
  • Managing Director
8yrs, 9mthSep 2016

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PCK
PainChek Ltd
19/12/2427,310,946N/A2,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
PCK
PainChek Ltd
30/06/25
Issued
7,082,154$0.045$318,696Issue of securities
PCK
PainChek Ltd
19/12/24
Issued
2,000,000$0.025$50,000Rights issue
PCK
PainChek Ltd
19/12/24
Issued
2,000,000$0.026$52,000Rights issue
PCK
PainChek Ltd
19/12/24
Expiry
12,611,867$0.026$327,908As advised by the company
PCK
PainChek Ltd
11/03/24
Issued
1,193,793$0.025$29,964Participation in share purchase plan